These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19055862)

  • 1. Immunoglobulin free light chains: do they have a role in plasma cell leukemia?
    Kar R; Dutta S; Bhargava R; Kumar R; Pati HP
    Hematology; 2008 Dec; 13(6):344-7. PubMed ID: 19055862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
    Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E
    Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.
    Mayo MM; Johns GS
    Contrib Nephrol; 2007; 153():44-65. PubMed ID: 17075223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolving use of serum free light chain assays in haematology.
    Pratt G
    Br J Haematol; 2008 May; 141(4):413-22. PubMed ID: 18318757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
    Hutchison CA; Plant T; Drayson M; Cockwell P; Kountouri M; Basnayake K; Harding S; Bradwell AR; Mead G
    BMC Nephrol; 2008 Sep; 9():11. PubMed ID: 18808676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance.
    Rajkumar SV; Kyle RA; Therneau TM; Clark RJ; Bradwell AR; Melton LJ; Larson DR; Plevak MF; Katzmann JA
    Br J Haematol; 2004 Nov; 127(3):308-10. PubMed ID: 15491291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biochemical and immunological findings of multiple myeloma].
    Asaoku H
    Nihon Rinsho; 2007 Dec; 65(12):2256-60. PubMed ID: 18069270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between on-line high-efficiency hemodiafiltration and conventional high-flux hemodialysis for polyclonal free light chain removal.
    Lamy T; Henri P; Lobbedez T; Comby E; Ryckelynck JP; Ficheux M
    Blood Purif; 2014; 37(2):93-8. PubMed ID: 24603634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of serum markers in the LRF CLL4 trial: β2-microglobulin but not serum free light chains, is an independent marker of overall survival.
    Pratt G; Thomas P; Marden N; Alexander D; Davis Z; Hussey D; Parry H; Harding S; Catovsky D; Begley J; Oscier D
    Leuk Lymphoma; 2016 Oct; 57(10):2342-50. PubMed ID: 26732125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum free light chains are reduced in endurance trained older adults: Evidence that exercise training may reduce basal inflammation in older adults.
    Heaney JL; Phillips AC; Drayson MT; Campbell JP
    Exp Gerontol; 2016 May; 77():69-75. PubMed ID: 26921802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum free light chains in clinical laboratory diagnostics.
    Jenner E
    Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney disease and plasma cell dyscrasias: ambiguous cases solved by serum free light chain dimerization analysis.
    Kukuy O; Kaplan B; Golderman S; Volkov A; Duek A; Leiba M; Ben-Zvi I; Livneh A
    Clin Exp Nephrol; 2019 Jun; 23(6):763-772. PubMed ID: 30734185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology of immunoglobulin free light chains and kidney injury.
    Basnayake K; Stringer SJ; Hutchison CA; Cockwell P
    Kidney Int; 2011 Jun; 79(12):1289-301. PubMed ID: 21490587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.
    Gottenberg JE; Aucouturier F; Goetz J; Sordet C; Jahn I; Busson M; Cayuela JM; Sibilia J; Mariette X
    Ann Rheum Dis; 2007 Jan; 66(1):23-7. PubMed ID: 16569685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum free light chain assessment in monoclonal gammopathy and kidney disease.
    Hutchison CA; Basnayake K; Cockwell P
    Nat Rev Nephrol; 2009 Nov; 5(11):621-8. PubMed ID: 19786994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum free light chain reference values: a critical approach.
    Altinier S; Seguso M; Zaninotto M; Varagnolo M; Adami F; Angeli P; Plebani M
    Clin Biochem; 2013 May; 46(7-8):691-3. PubMed ID: 23384536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ELISAs for free human immunoglobulin light chains in serum: improvement of assay specificity by using two specific antibodies in a sandwich detection method.
    Nakano T; Nagata A
    J Immunol Methods; 2004 Oct; 293(1-2):183-9. PubMed ID: 15541287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free immunoglobulin light-chain serum levels in the follow-up of patients with monoclonal gammopathies: correlation with 24-hr urinary light-chain excretion.
    Alyanakian MA; Abbas A; Delarue R; Arnulf B; Aucouturier P
    Am J Hematol; 2004 Apr; 75(4):246-8. PubMed ID: 15054820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical usefulness of serum free light chain measurement in monoclonal gammopathy].
    Shimazaki C; Murakami H; Sawamura M; Matsuda M; Kinoshita T; Hata H; Sugiura I; Tsushita K; Nagura E; Kosugi H; Itoh J; Shimizu K
    Rinsho Ketsueki; 2010 Apr; 51(4):245-52. PubMed ID: 20467220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical value of the blood measurement of the free light chains of immunoglobulins].
    Bidet A; Marit G; Bérard AM
    Ann Biol Clin (Paris); 2008; 66(4):427-31. PubMed ID: 18725344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.